SUBCUTANEOUS THERAPY (SCIT)
SUBCUTANEOUS SPECIFIC IMMUNOTHERAPY
SUBCUTANEOUS L-TYROSINE-ADSORBED ALLERGOID
Anallergo's allergoid treatment is an allergen extract chemically modified with glutaraldehyde.
The modified allergenic protein, while retaining its immunogenicity, shows decreased allergenicity and hence a lower risk of side effects.
The product is administered subcutaneously in the upper arm.
Treatment should only be performed under direct medical supervision.
The patient must remain under medical observation for at least 30 minutes after administration of the vaccine.
STARTING TREATMENT PLAN
N. 1 - 5.0 ml light blue label vial containing 10,000 allergen units/ml of 5 ml.
No. 1 - 5.0 ml light blue label vial containing 10,000 allergen units/ml of 5 ml.
Vials are packed in a protective, rigid plastic container.